WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security ...

Established industrial systems have historically been designed to function as linear frameworks, transforming raw materials—including fossil and renewable resources—into products that become waste ...

Cory has been a professional trader for two decades. In addition to trading and investing he's widely published and coaches individual clients on the finer points of gaining an edge in the market.

For the end of this year, Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting. And readers have made it easy for us—it’s clear what kind of story ...

Night-time collisions with robotic lawnmowers are a significant animal welfare and conservation problem for hedgehogs as they often suffer serious or even fatal injuries. In order to make the ...

Across 2024, more than 4,940 workers lost their jobs at Massachusetts life sciences companies. The Business Journal has a monthly breakdown of layoffs at each local company. Across 2024, more than ...

EXPLAINS. RIGHT NOW, EVEN THE PHARMACY DIDN’T KNOW THEY WERE FAKE. ALLEN’S PHARMACY WOUND UP WITH A BOGUS BATCH OF THESE COVID TESTS, BUT THE OWNER TELLS ME THEY ONLY SOLD A HANDFUL OF THE ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs with high cash burn and no revenue. Biotech IPOs show resilience. Recent market ...

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance. New techniques are being made possible by advancements ...

Local biotech Heron Therapeutics is relocating its headquarters from San Diego to North Carolina, where it says the area’s burgeoning biotech scene “provides ample space for growth and ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...